DCGI

NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for…

A novel solution will offer better absorption of the drug resulting in quick relief and faster recovery to patients suffering from…

Mylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylan's Global President and…

Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…

The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for…

In a letter outlining the issues faced by the industry, the manufacturers highlight that the reputation and future of the pharma…

He will be be India's first full time DCGI in nearly two years after Dr G N Singh left the position in early 2018

Stempeucel is used in the treatment of Buerger’s disease

Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma…

The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug In a…